Nvidia Delays SOCAMM Technology to Next-Gen Processors
May 15, 2025 - 19:57
Reliability and supply chain challenges have reportedly led Nvidia to postpone the introduction of its SOCAMM technology. Initially intended for the Blackwell Ultra GB300, the rollout of this advanced technology has now been rescheduled for the upcoming Rubin and Rubin Ultra processors.
This decision underscores the complexities that technology companies face in maintaining production timelines, particularly in the current climate of global supply chain disruptions. SOCAMM, which stands for Scalable On-Chip Adaptive Memory Management, is anticipated to enhance the performance and efficiency of Nvidia's next-generation processors.
The delay may have implications for developers and consumers alike, as they await the benefits of this innovative technology. Nvidia's commitment to ensuring that the SOCAMM technology meets its reliability standards reflects its dedication to delivering high-quality products. As the company navigates these challenges, stakeholders will be closely monitoring the situation for updates on the revised launch timeline.
MORE NEWS
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...